Evidence map›Paper›PMID 25518956›Full record

Trial reportClinical trials (London, England)2015

Reducing lost to follow-up in a large clinical trial of prevention of mother-to-child transmission of HIV: the Breastfeeding, Antiretrovirals and Nutrition study experience.

Christopher J Sellers, Hana Lee, Charles Chasela, Dumbani Kayira, Alice Soko, Innocent Mofolo, Sascha Ellington, Michael G Hudgens, Athena P Kourtis, Caroline C King and 3 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical trials (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Discontinuation and loss to follow-up rates in clinical trials of intravitreal anti-vascular endothelial growth factor injections.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Christopher J SellersDivision of Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Hana LeeDepartment of Biostatistics, School of Public Health, Brown University, Providence, RI, USA.
Charles ChaselaUNC Project, Lilongwe, Malawi Division of Epidemiology and Biostatistics, Faculty of Health Sciences, School of Public Health, University of Witwatersrand, Johannesburg, South Africa.
Dumbani KayiraUNC Project, Lilongwe, Malawi.
Alice SokoUNC Project, Lilongwe, Malawi.
Innocent MofoloUNC Project, Lilongwe, Malawi.
Sascha EllingtonDivision of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Michael G HudgensDepartment of Biostatistics, School of Public Health, University of North Carolina, Chapel Hill, NC, USA.
Athena P KourtisDivision of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Caroline C KingDivision of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Denise J JamiesonDivision of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Charles van der HorstDivision of Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, NC, USA cvdh@med.unc.edu.
BAN Study Team

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
UNC CENTER FOR HEALTH PROMOTION AND DISEASE PREVENTIONU48DP001944 · DP · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AMMERMAN, ALICE S · 2009 to 2013
$15.1M
UNC Center for Health Promotion and Disease PreventionU48DP000059 · DP · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AMMERMAN, ALICE S · 2004 to 2009
$14.4M
Vanderbilt University-CIDRZ AIDS International Training and Research ProgramD43TW001035 · FIC · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 1998 to 2014
$10.9M
AIDS INTERNATIONAL TRAINING AND RESEARCH PROGRAMD43TW001039 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ADIMORA, ADAORA A · 1998 to 2013
$9.9M
Training in Infectious Disease Epidemiology (TIDE)T32AI070114 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Brian W Pence · 2007 to 2026
$4.0M
ACL HHS U48DP001944FIC NIH HHS D43 TW001035FIC NIH HHS D43 TW001039FIC NIH HHS R24TW00798FIC NIH HHS TW01039-06NCCDPHP CDC HHS U48 DP000059NCCDPHP CDC HHS U48-DP000059-01NCCDPHP CDC HHS U48 DP001944NCCDPHP CDC HHS U48-DP001944-01NIAID NIH HHS 5T32AI070114-08NIAID NIH HHS P30 AI042853NIAID NIH HHS P30 AI050410NIAID NIH HHS P30-AI50410NIAID NIH HHS T32 AI070114PHS HHS U48-CCU409660-09
6 · The paper itself

Abstract

BACKGROUND/

aimsRetaining patients in prevention of mother-to-child transmission of HIV studies can be challenging in resource-limited settings, where high lost to follow-up rates have been reported. In this article, we describe the effectiveness of methods used to encourage retention in the Breastfeeding, Antiretrovirals, and Nutrition study and analyze factors associated with lost to follow-up in the study.

methodsThe Breastfeeding, Antiretrovirals, and Nutrition clinical trial was designed to evaluate the efficacy of three different mother-to-child HIV transmission prevention strategies. Lower than expected participant retention prompted enhanced efforts to reduce lost to follow-up during the conduct of the trial. Following study completion, we employed regression modeling to determine predictors of perfect attendance and variables associated with being lost to follow-up.

resultsDuring the study, intensive tracing efforts were initiated after the first 1686 mother-infant pairs had been enrolled, and 327 pairs were missing. Of these pairs, 60 were located and had complete data obtained. Among the 683 participants enrolling after initiation of intensive tracing efforts, the lost to follow-up rate was 3.4%. At study's end, 290 (12.2%) of the 2369 mother-infant pairs were lost to follow-up. Among successfully traced missing pairs, relocation was common and three were deceased. Log-binomial regression modeling revealed higher maternal hemoglobin and older maternal age to be significant predictors of perfect attendance. These factors and the presence of food insecurity were also significantly associated with lower rates of lost to follow-up.

conclusionIn this large HIV prevention trial, intensive tracing efforts centered on reaching study participants at their homes succeeded in finding a substantial proportion of lost to follow-up participants and were very effective in preventing further lost to follow-up during the remainder of the trial. The association between food insecurity and lower rates of lost to follow-up is likely related to the study's provision of nutritional support, including a family maize supplement, which may have contributed to patient retention.

Indexed as

Lost to Follow-UpAdolescentAdultAnti-HIV AgentsBreast FeedingChild, PreschoolFemaleHIV InfectionsHumansInfantInfant, NewbornInfectious Disease Transmission, VerticalMothersPregnancyResearch DesignYoung AdultAnti-HIV AgentsAntiretroviral therapyhuman immunodeficiency viruslost to follow-upprevention of mother-to-child transmissionretentiontracing

Identifiers

PMID25518956
PMCPMC4355163

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.